April 2026: As of April 1, 2026, there are 73 pending lawsuits in MDL 3163 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation , which involves claims against Novo Nordisks Wegovy
VAL itself is made up of several databases linkable with the unique identifiers of each patient, and these databases contain individual-level data on age, sex, dispensed prescription drugs, diagnoses, hospitalizations, healthcare consultations, economic transactions, as well as migration and death
Do not use if the solution is cloudy or contains visible particles
doi: 10.1038/ki.2014.246 44 Mori ITI
Mitochondria as signaling organelles